Tavist (clemastine fumarate)

Company
Sandoz Pharmaceuticals

Approval Status
Approved November 1996

Treatment for
cold symptoms, including sneezing and runny nose

Possible similar drugs
Tavist

Areas
Respiratory

Tavist-D has been approved for the treatment of cold symptoms, including sneezing and runny nose. The FDA decision results from well-controlled clinical studies of the antihistamine clemastive fumarate, the active ingredient that differentiates the Tavist product from others.

Tavist_177 Drug Information

The Tavist_177 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top